These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 753671)

  • 1. A consideration of some methods by which the cost of potency assays for diphtheria and tetanus vaccines might be reduced.
    Knight PA
    Dev Biol Stand; 1978; 41():67-72. PubMed ID: 753671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines.
    Knight PA; Roberts PA
    Dev Biol Stand; 1986; 65():245-53. PubMed ID: 3493931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
    Winsnes R; Sesardic D; Daas A; Behr-Gross ME
    Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay.
    Aggerbeck H; Heron I
    Dev Biol Stand; 1996; 86():297-301. PubMed ID: 8785958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International collaborative studies on potency assays of diphtheria and tetanus toxoids.
    Van Ramshorst JD; Sundaresan TK; Outschoorn AS
    Bull World Health Organ; 1972; 46(2):263-76. PubMed ID: 4537488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of an informal meeting about alternative methods for the potency control of the diphtheria and tetanus components in vaccines.
    Kreeftenberg JG
    Dev Biol Stand; 1986; 65():261-6. PubMed ID: 3493932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine.
    Iwaki M; Komiya T; Fukuda T; Arakawa Y; Takahashi M
    Jpn J Infect Dis; 2003 Aug; 56(4):183-5. PubMed ID: 14583650
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of national standards in the control of standardization of diphtheria and tetanus anatoxins. Conditions of measurement in international units and immunogenic value of tetanus anatoxin for guinea pigs and mice].
    Demian L; Lazăr M
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):297-302. PubMed ID: 5400034
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological standardization of potency testing of diphtheria-tetanus-pertussis vaccines.
    Csizér Z; Zsidai J
    Ann Immunol Hung; 1979; 19():53-74. PubMed ID: 552225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency assay of diphtheria and tetanus toxoids some theoretical and practical considerations.
    Lyng J
    Dev Biol Stand; 1986; 64():47-50. PubMed ID: 3792657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use.
    Winsnes R; Hendriksen C; Sesardic D; Akkermans A; Daas A
    Dev Biol Stand; 1999; 101():277-88. PubMed ID: 10566802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in vivo and in vitro methods for determining unitage of diphtheria antitoxin in adsorbed diphtheria-tetanus (DT) and diphtheria-tetanus-pertussis (DTP) vaccines.
    Shinde YP; Jadhav SS
    Dev Biol Stand; 1996; 86():245-60. PubMed ID: 8785954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in animal usage for potency testing of diphtheria and tetanus toxoids.
    Stainer DW; Jakus CM; Sparkes JD
    Dev Biol Stand; 1986; 65():241-4. PubMed ID: 3556773
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of national norms in the control of standardization of diphtheria and tetanus anatoxins. II. Checking of simple and combined preparations of diphtheria and tetanus anatoxin with the aid of national standards].
    Chirescu N; Demian L
    Arch Roum Pathol Exp Microbiol; 1971 Mar; 30(1):143-50. PubMed ID: 5096860
    [No Abstract]   [Full Text] [Related]  

  • 17. Vero cell assay validation of an alternative to the Ph. Eur. diphtheria potency tests.
    Gommer AM
    Dev Biol Stand; 1996; 86():217-24. PubMed ID: 8785952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria.
    Vrancheva S; Vulchev V; Bachev S
    Prog Immunobiol Stand; 1970; 4():548-52. PubMed ID: 5482199
    [No Abstract]   [Full Text] [Related]  

  • 19. [The determination of the protective potency of the diphtheria component in combined vaccines by the indirect hemagglutination (IHA) method].
    Unver SD; Ozcengiz E
    Mikrobiyol Bul; 1990 Oct; 24(4):327-35. PubMed ID: 2287290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of reductions in the numbers of animals used for the potency assay of the diphtheria and tetanus components of adsorbed vaccines by the methods of the European pharmacopoeia.
    Hendriksen CF; van der Gun JW; Marsman FR; Kreeftenberg JG
    J Biol Stand; 1987 Oct; 15(4):353-62. PubMed ID: 3680303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.